DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8642sh/analyzing_the) has announced the addition of the "Analyzing the Global Generics Industry 2014" report to their offering.
This in-depth analysis of the global generics industry includes an industry definition, historical development of the industry, industry statistics, value and volume analysis, industry segmentation by geography, amongst others. We analyze the issue of patent expiries by therapeutic areas in details, looking at what the impact is on the generic drugs market. We also look at the industry structure, market entry as well as research & development in the industry. A Porter's Five Forces Strategy analysis of the global generics industry is also included in the report.
The impact of regulatory framework on the generics industry in Europe, Japan and the United States is analyzed in the report, along with the trends and challenges in the global generics industry. We also look at the popularity of small molecule generic drugs as well as the growing focus on biosimilars. Challenge of life cycle management strategies are also looked at. Global generics industry strategies are analyzed as well.
An important aspect of the global generics market is the pricing and reimbursement of generic drugs in major markets. We analyze the pricing and reimbursement in the key markets of Australia, Austria, China, Czech Republic, France, Germany, Hungary, India, Italy, Japan, Norway, Poland, Romania, Spain, Sweden, the UK and the United States.
Key Topics Covered:
A. Executive Summary
B. Analyzing the Global Generics Industry
C. Global Generics Industry: Porter's Five Forces Strategy Analysis
D. Regulatory Framework & Impact on the Generics Industry
E. Industry Trends & Challenges
F. Industry Strategies
G. Global Generics Industry: Analysis of Major Markets
H. Pricing and Reimbursement of Generics: An Analysis by Major Markets
I. Global Generics Industry Forecast
J. Major Industry Players
- Bayer AG
- Biogaran S.A.S.
- China Grand Pharmaceutical and Healthcare Holdings Limited
- Daiichi Sankyo Co., Ltd.
- Dr. Reddy's Laboratories Limited (DRL)
- Esteve Group
- Hospira Inc
- Mylan Inc.
- Nichi-iko Pharmaceutical
- Novartis AG
- Par Pharmaceutical Companies, Inc.
- Perrigo Company PLC
- Ratiopharm Group
- STADA Arzneimittel AG
- Sawai Pharmaceutical Co., Ltd
- Teva Pharmaceutical Industries Limited
For more information visit http://www.researchandmarkets.com/research/8642sh/analyzing_the